Patients with diabetic kidney disease (DKD) and anemia have no worse, and possibly better, cardiovascular outcomes from finerenone treatment.

Anemia is more common in later-stage chronic kidney disease (CKD), with diabetes and dialysis increasing the risk. Treating the underlying cause can improve symptoms and quality of life.

Anemia in chronic kidney disease (CKD) causes the body to produce too few red blood cells. People with advanced kidney disease tend to develop this condition, and it can increase the risk of ...

Related Content “These longitudinal data support the concept that anemia is suboptimally managed among patients with NDD-CKD in the real-world setting,” Dr Lopes said. “These data point to ...

Chronic kidney disease and anemia—both individually and together ... which supports the concept that this biomarker may be elevated before HF symptoms and signs develop,” the authors reported.

SGLT2 inhibitors significantly improve hemoglobin and hematocrit levels in CKD patients, enhancing anemia management. The KDIGO 2024 guideline endorses SGLT2 inhibitors for CKD patients ...

Anemia is caused by CKD because of the lesser production of a hormone called erythropoietin. Erythropoietin is involved in stimulating the bone marrow, the spongy tissue in the bone involved in ...

The Food and Drug Administration (FDA) has granted Fast Track designation to DISC-0974 for the treatment of anemia in patients with nondialysis dependent chronic kidney disease (NDD-CKD).

The goal in treating anemia in chronic kidney disease (CKD) is to help your body make more healthy red blood cells. The exact treatment you'll get depends on what causes your anemia and your symptoms.

It's done just like a CBC. Low iron levels are a common cause of anemia in chronic kidney disease. They can happen if there isn't enough iron in the foods you eat, or if your body has a hard time ...